This invention relates to prostaglandin agonists, methods of using such prostaglandin agonists, pharmaceutical compositions containing such prostaglandin agonists and kits containing such prostaglandin agonists. The prostaglandin agonists are useful for the treatment of bone disorders including osteoporosis.

Cette invention concerne les agonistes de prostaglandine, méthodes d'utiliser de tels agonistes de prostaglandine, compositions pharmaceutiques contenant de tels agonistes et kits de prostaglandine contenant de tels agonistes de prostaglandine. Les agonistes de prostaglandine sont utiles pour le traitement des désordres d'os comprenant l'ostéoporose.